PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on January 29, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: January 29, 2026 RaQualia Pharma Inc. [4579.T] TOKYO, Jan 29 (Kyodo) -- RaQualia Pharma Inc. (4579), represented by President Masaki Suto, has announced that the subscription payment process for its new share issuance to third parties has been completed as of today. The company had previously resolved on this issuance during its board meeting held on December 12, 2025. The shares issued amount to 1,555,900 ordinary shares at an issue price of 907 yen per share, ra